Metastatic renal cell carcinoma (mRCC) is one of the most treatment-resistant malignancies to conventional cytotoxic chemotherapy. Previously, systemic treatment was limited to cytokine therapy [1]. Treatment options have expanded considerably for patients with mRCC with the greater understanding of the molecular mechanisms involved [2–4]. Seven molecular targeted agents for the treatment of mRCC are now approved, with significant improvements in progression-free survival (PFS) but rarely with an impact on overall survival (OS) [5].
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2igy6k2
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Astrophel' is a fanciful half-Greek anagram for the poet's own name, and Stella (Star) designates Lady Penelope Devereux, who at abo...
-
The impact of industrialised societies on Earth has been described in a mathematical formula that should scare us all, says Owen Gaffney ...
-
Bumblebees have shown they can learn how to push a ball into a hole to get a reward, staking their claim to be considered tool users from ...
-
is and in to a was not you i of it the be he his but for are this that by on at they with which she or from had we will have an what been on...
-
Abstract Combating gliomagenic global immunosuppression is the one of the emerging key for improving prognosis in malignant glioma. Apopt...
-
Publication date: February 2017 Source: Cryobiology, Volume 74 Author(s): Reza Masoudi, Ahmad Zare Shahneh, Armin Towhidi, Hamid Kohram, A...
-
by Huiyuan Zhu, Lian Zhang, Yali Wang, Preeti Hamal, Xiaofang You, Haixia Mao, Fei Li, Xiwen Sun The aim of this study was to assess whethe...
-
Abstract: Patients with neurofibromatosis type 1 (NF-1) have a well-known predisposition for certain types of malignancies, including lympho...
-
Party Themes and Group Games You Sent In! These ideas sound like a lot of fun for everyone. You are sure to find some new ideas and inspirat...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου